NOVEL NUCLEIC ACID SEQUENCING TECHNOLOGY DEVELOPMENT (R21): RFA-HG-15-031

Components of Participating Organizations

National Human Genome Research Institute

Application Receipt Date(s): October 27, 2015; July 14, 2016; June 15, 2017, by 5:00 PM local time of applicant organization.

Funding Opportunity Purpose

This Funding Opportunity Announcement (FOA) solicits R21 grant applications to develop novel technologies that will enable new approaches to DNA and direct RNA sequencing. Applicants may propose to develop novel complete sequencing systems, investigate challenges underlying key novel system components, or propose improvements of at least an order of magnitude improvement to existing systems. Exploration of methods other than those currently in use is highly encouraged. High-risk/high-payoff applications are appropriate to achieve the goals of this FOA.

Also note:

Novel Nucleic Acid Sequencing Technology Development (R01): RFA-HG-15-032

Details at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-15-032.html.

Novel Nucleic Acid Sequencing Technology Development (R43/R44): RFA-HG-15-033

Details at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-15-033.html.

Complete details available at: http://grants.nih.gov/grants/guide/rfa-files/RFA-HG-15-031.html.

ADVANCED DEVELOPMENT OF INFORMATICS TECHNOLOGIES FOR CANCER RESEARCH AND MANAGEMENT (U24): PAR-15-331

Components of Participating Organizations

National Cancer Institute

Application Receipt/Submission Date(s): November 20, 2015; June 14, 2016; November 21, 2016; June 14, 2017; November 20, 2017; June 14, 2018, by 5:00 PM local time of applicant organization.

Funding Opportunity Purpose

The purpose of this Funding Opportunity Announcement (FOA) is to invite Cooperative Agreement (U24) applications for advanced development and enhancement of emerging informatics technologies to improve the acquisition, management, analysis, and dissemination of data and knowledge across the cancer research continuum, including cancer biology, cancer treatment and diagnosis, cancer prevention, cancer control and epidemiology, and/or cancer health disparities. As a component of the NCI’s Informatics Technology for Cancer Research (ITCR) Initiative, this FOA focuses on emerging informatics technology, defined as one that has passed the initial prototyping and pilot development stage, has demonstrated potential to have a significant and broader impact, has compelling reasons for further improvement and enhancement, and has not been widely adopted in the cancer research field. …